VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN

被引：0
|
作者：
Ameri, A. [1 ]
Shahrad, B. [1 ]
Madani, H. [1 ]
Fazlalizadeh, A. [1 ]
Mousavizadeh, A. [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Vinorelbine and capecitabine combination as first-line treatment in patients with metastatic breast cancer: Final results of a multicentric trial in Egypt
    Elghazaly, H.
    Tawfik, H.
    Mahrous, M.
    Meshref, M. M.
    Sakr, A.
    Haddad, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] A combination of vinorelbine and carboplatin as first line treatment for patients with metastatic breast cancer - A phase II study.
    Protheroe, AS
    Rodwell, S
    Aram, H
    Dodwell, D
    Crawford, M
    Bradley, C
    Perren, TJ
    Hill, S
    Joffe, JK
    BRITISH JOURNAL OF CANCER, 2001, 85 : 50 - 50
  • [3] Oral Vinorelbine in Combination With Capecitabine as a First Line Treatment in Patients (pts) With Metastatic Breast Cancer (MBC) Previously Treated With Anthracyclines ± Taxanes - Preliminary Results of a Multicentric Phase II Trial in Egypt
    Kandil, A.
    Hamada, E.
    Moawad, M.
    El Arab, L. Ezz
    Metwalli, H.
    Bathiouny, M.
    Mourad, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S351 - S351
  • [4] A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)
    Palumbo, Raffaella
    Bernardo, Antonio
    Strada, Maria Rosa
    Poggi, Guido
    Delmonte, Angelo
    Teragni, Cristina
    Frascaroli, Mara
    Bernardo, Giovanni
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [5] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first line treatment in metastatic breast cancer
    Shamseddine, A.
    Bitar, N.
    Dheiny, M.
    Chehal, A.
    Abou Mourad, Y.
    Jalloul, R.
    Dandashi, A.
    Wehbet, M.
    Abu Nasr, T.
    El Saghir, N. S.
    EJC SUPPLEMENTS, 2004, 2 (03): : 131 - 131
  • [6] Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first line treatment of metastatic breast cancer: Results of a multicenter phase II study
    Riccardi, A
    Brugnatelli, S
    Danova, M
    Giordano, M
    Pugliese, P
    Luchena, G
    Grasso, D
    Trotti, G
    Berte, R
    Pansini, G
    Tinelli, C
    TUMORI, 2006, 92 (01) : 6 - 12
  • [7] Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
    Infante, Jeffrey R.
    Yardley, Denise A.
    Burris, Howard A., III
    Greco, F. Anthony
    Farley, Cindy P.
    Webb, Charles
    Spigel, David R.
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (01) : 23 - 28
  • [8] Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
    Ferrario, Cristiano
    Strepponi, Ivan
    Esfahani, Khashayar
    Charamis, Helen
    Langleben, Adrian
    Scarpi, Emanuela
    Nanni, Oriana
    Miller, Wilson H., Jr.
    Panasci, Lawrence C.
    PLOS ONE, 2016, 11 (12):
  • [9] Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer - a phase II trial
    Palumbo, R.
    Bernardo, A.
    Strada, M.
    Teragni, C.
    Poggi, G.
    Frascaroli, M.
    Amatu, A.
    Palumbo, I.
    Bernardo, G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 177 - 177
  • [10] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
12345